Methylphenidate HCI EP/IP EP / IP / USP

Global calcium is one of the leading manufacturers and exporters of Methyl phenidate Hydrochloride CAS No. 298-59-9, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, global calcium has stood the test of time since its inception in 1979.

As manufacturer of Methyl phenidate Hydrochloride   we hereby state the following facts about the drug:

Methyl phenidate Hydrochloride is a novel drug which has been shown to be effective in the treatment attention deficit hyperactivity disorder (ADHD) and narcolepsy. ADHD is a neurodevelopmental disorder characterised by symptoms of inattention, hyperactivity, impulsivity, and emotional dysregulation that are excessive and pervasive.

Methyl phenidate Hydrochloride is indicated for the:

• It is typically indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and for narcolepsy in adults.

Mechanism of action

• Methylphenidate blocks the reuptake of the neurotransmitters norepinephrine (NE) and dopamine in presynaptic neurons while inhibiting the transport of these neurotransmitters, increasing the concentration of dopamine and NE in the synaptic cleft. This creates the classic stimulant effect within the central nervous system (CNS), primarily in the prefrontal cortex.

Global calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market.